• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Industry expects to recoup investments in value-based models like ACOs

Article

Healthcare leaders expect to recoup investments in technology, staff and facilities that support new models of care such as accountable care organizations within four years, according to a new survey.

Healthcare leaders expect to recoup investments in technology, staff and facilities that support new models of care,including accountable care organizations, within four years, American College of Healthcare Executives listed population health as the 8th biggest concern, ahead of technology and personnel shortages, according to KPMG. "Healthcare providers are facing a seismic shift in the coming years, largely because government and commercial payers will increasingly decline to pay for avoidable hospital visits," Kuehn said. "Providers and other participants in the care delivery system need the real time data and analytic tools to not only manage and improve the quality of care provided, but also the ability to measure costs to operate efficiently."

"Our clients see benefits from population health management programs as a part of the solution to reduce avoidable medical costs and variability in care," said West Johnson, a KPMG advisory partner who heads provider transformation. "Preventive care is given a big priority in these programs, since they deliver improvements in efficient and effective care with a high degree of patient engagement."

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.